Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $66.02 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $20.43 | 1 | $0 (2022) |
| Exact Sciences Corporation | $15.81 | 1 | $0 (2023) |
| Novo Nordisk Inc | $15.45 | 1 | $0 (2023) |
| Genentech USA, Inc. | $14.33 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $31.26 | 2 | Exact Sciences Corporation ($15.81) |
| 2022 | $20.43 | 1 | Biohaven Pharmaceutical Holding Company Ltd. ($20.43) |
| 2021 | $14.33 | 1 | Genentech USA, Inc. ($14.33) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Oncology | ||||||
| 05/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 10/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: PRIMARY CARE | ||||||
| 12/17/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 422 | 432 | $79,689 | $20,962 |
| 2022 | 11 | 708 | 725 | $129,536 | $43,026 |
| 2021 | 14 | 1,082 | 1,173 | $174,676 | $63,104 |
| 2020 | 9 | 685 | 756 | $108,774 | $29,893 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 180 | $36,497 | $9,534 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 109 | 109 | $24,082 | $5,973 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 21 | $5,022 | $1,571 | 31.3% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 11 | 11 | $4,290 | $1,538 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,124 | $1,127 | 22.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 15 | $2,860 | $686.16 | 24.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 23 | $1,078 | $372.60 | 34.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 38 | $470.00 | $81.40 | 17.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 18 | 19 | $266.00 | $79.80 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 311 | 325 | $58,055 | $17,811 | 30.7% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 57 | 57 | $21,033 | $8,073 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 111 | 111 | $23,327 | $7,120 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 70 | $14,768 | $6,199 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,000 | $1,346 | 33.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 17 | 17 | $2,482 | $868.16 | 35.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 17 | 17 | $2,703 | $522.88 | 19.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 13 | $1,042 | $450.42 | 43.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 15 | 15 | $678.00 | $244.97 | 36.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 14 | $708.00 | $228.07 | 32.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 73 | 73 | $740.00 | $162.65 | 22.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 527 | 579 | $101,825 | $32,819 | 32.2% |
| 87636 | Sarscov2 & inf a&b amp prb | Office | 2021 | 66 | 66 | $13,546 | $9,414 | 69.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 101 | 101 | $19,590 | $7,048 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 81 | $16,707 | $6,809 | 40.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 80 | 81 | $11,826 | $4,156 | 35.1% |
About Kelli Maxwell
Kelli Maxwell is a Family healthcare provider based in Basehor, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2017. The National Provider Identifier (NPI) number assigned to this provider is 1790226744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelli Maxwell has received a total of $66.02 in payments from pharmaceutical and medical device companies, with $31.26 received in 2023. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($66.02).
As a Medicare-enrolled provider, Maxwell has provided services to 2,897 Medicare beneficiaries, totaling 3,086 services with total Medicare billing of $156,985. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Basehor, KS
- Active Since 03/10/2017
- Last Updated 10/16/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1790226744
Products in Payments
- NURTEC ODT (Drug) $20.43
- Cologuard Collection Kit (Device) $15.81
- Xofluza (Drug) $14.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.